Ticker Details
Kiniksa Pharmaceuticals, Ltd.
IPO Date:	May 21, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 2.65%
Avg Daily Range (30 D):	$0.92 | 2.17%
Avg Daily Range (90 D):	$0.68 | 1.65%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.51M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	1,700
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$2.96M
Avg Institutional Trade (90 D):	$2.21M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$2.61M
Avg Closing Trade (90 D):	$2.16M
Avg Closing Volume:	83.15K

News

Oct 17, 2025 @ 12:00 PM Kiniksa Pharmaceuticals Announces U.S. Orphan Drug... Source: Kiniksa Pharmaceuticals International

Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A

May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A

Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights

Feb 20, 2025 @ 9:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter a... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.49	$.25	$.24
Diluted EPS	$.45	$.23	$.23
Revenue	$597.97M	$180.86M	$156.8M
Gross Profit	$523.35M	$160.6M	$138.19M
Net Income / Loss	$35.92M	$18.44M	$17.83M
Operating Income / Loss	$38.15M	$24.02M	$20.16M
Cost of Revenue	$74.62M	$20.26M	$18.6M
Net Cash Flow	$77.48M	$-17.18M	$34.91M
PE Ratio	96.67